nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1A1—kidney cancer	0.206	1	CbGaD
Propofol—UGT1A1—Pazopanib—kidney cancer	0.0504	0.0993	CbGbCtD
Propofol—CYP1B1—Erlotinib—kidney cancer	0.0416	0.082	CbGbCtD
Propofol—CYP1B1—Paclitaxel—kidney cancer	0.0381	0.075	CbGbCtD
Propofol—UGT1A1—Erlotinib—kidney cancer	0.036	0.0708	CbGbCtD
Propofol—UGT1A9—Sorafenib—kidney cancer	0.0358	0.0704	CbGbCtD
Propofol—UGT1A1—Sorafenib—kidney cancer	0.0292	0.0576	CbGbCtD
Propofol—CYP1B1—Doxorubicin—kidney cancer	0.0205	0.0404	CbGbCtD
Propofol—CYP1A1—Erlotinib—kidney cancer	0.0183	0.036	CbGbCtD
Propofol—CYP2D6—Temsirolimus—kidney cancer	0.0179	0.0353	CbGbCtD
Propofol—CYP3A4—Everolimus—kidney cancer	0.0169	0.0332	CbGbCtD
Propofol—CYP2C8—Pazopanib—kidney cancer	0.0148	0.0291	CbGbCtD
Propofol—ALB—Erlotinib—kidney cancer	0.0136	0.0269	CbGbCtD
Propofol—CYP1A2—Pazopanib—kidney cancer	0.0114	0.0225	CbGbCtD
Propofol—CYP3A4—Temsirolimus—kidney cancer	0.0114	0.0225	CbGbCtD
Propofol—CYP2B6—Sorafenib—kidney cancer	0.0113	0.0223	CbGbCtD
Propofol—CYP2C9—Capecitabine—kidney cancer	0.0107	0.0212	CbGbCtD
Propofol—CYP2C8—Erlotinib—kidney cancer	0.0105	0.0208	CbGbCtD
Propofol—CYP2C8—Paclitaxel—kidney cancer	0.00965	0.019	CbGbCtD
Propofol—CYP2D6—Pazopanib—kidney cancer	0.00942	0.0185	CbGbCtD
Propofol—CYP2C8—Sorafenib—kidney cancer	0.00857	0.0169	CbGbCtD
Propofol—CYP1A2—Erlotinib—kidney cancer	0.00816	0.0161	CbGbCtD
Propofol—CYP2C19—Sorafenib—kidney cancer	0.00719	0.0142	CbGbCtD
Propofol—CYP2B6—Doxorubicin—kidney cancer	0.00687	0.0135	CbGbCtD
Propofol—CYP2C9—Paclitaxel—kidney cancer	0.00673	0.0133	CbGbCtD
Propofol—CYP2D6—Erlotinib—kidney cancer	0.00672	0.0132	CbGbCtD
Propofol—CYP1A2—Sorafenib—kidney cancer	0.00663	0.0131	CbGbCtD
Propofol—CYP3A4—Pazopanib—kidney cancer	0.00599	0.0118	CbGbCtD
Propofol—CYP2C9—Sorafenib—kidney cancer	0.00598	0.0118	CbGbCtD
Propofol—CYP2D6—Sorafenib—kidney cancer	0.00547	0.0108	CbGbCtD
Propofol—CYP2D6—Vinblastine—kidney cancer	0.0054	0.0106	CbGbCtD
Propofol—CYP3A4—Erlotinib—kidney cancer	0.00427	0.00842	CbGbCtD
Propofol—UGT1A1—urine—kidney cancer	0.00409	0.0919	CbGeAlD
Propofol—CYP3A4—Paclitaxel—kidney cancer	0.00391	0.0077	CbGbCtD
Propofol—CYP3A4—Sorafenib—kidney cancer	0.00348	0.00684	CbGbCtD
Propofol—CYP3A4—Vinblastine—kidney cancer	0.00343	0.00676	CbGbCtD
Propofol—CYP3A4—Vincristine—kidney cancer	0.00337	0.00664	CbGbCtD
Propofol—CYP2D6—Doxorubicin—kidney cancer	0.00332	0.00653	CbGbCtD
Propofol—CYP3A4—Sunitinib—kidney cancer	0.00282	0.00554	CbGbCtD
Propofol—UGT1A8—renal system—kidney cancer	0.0023	0.0517	CbGeAlD
Propofol—UGT1A8—kidney—kidney cancer	0.00222	0.0499	CbGeAlD
Propofol—CYP2C19—urine—kidney cancer	0.00222	0.0498	CbGeAlD
Propofol—CYP3A4—Doxorubicin—kidney cancer	0.00211	0.00415	CbGbCtD
Propofol—FAAH—nephron tubule—kidney cancer	0.00184	0.0413	CbGeAlD
Propofol—CYP1A2—urine—kidney cancer	0.00181	0.0407	CbGeAlD
Propofol—CYP2C9—urine—kidney cancer	0.00172	0.0386	CbGeAlD
Propofol—FAAH—renal system—kidney cancer	0.00167	0.0375	CbGeAlD
Propofol—CYP2E1—urine—kidney cancer	0.00163	0.0366	CbGeAlD
Propofol—FAAH—cortex of kidney—kidney cancer	0.00157	0.0353	CbGeAlD
Propofol—FAAH—gonad—kidney cancer	0.0015	0.0337	CbGeAlD
Propofol—UGT1A9—renal system—kidney cancer	0.00146	0.0328	CbGeAlD
Propofol—UGT1A9—kidney—kidney cancer	0.00141	0.0317	CbGeAlD
Propofol—CYP3A4—urine—kidney cancer	0.00131	0.0295	CbGeAlD
Propofol—CYP2D6—urine—kidney cancer	0.00129	0.029	CbGeAlD
Propofol—SCN4A—renal system—kidney cancer	0.00109	0.0244	CbGeAlD
Propofol—SCN4A—kidney—kidney cancer	0.00105	0.0236	CbGeAlD
Propofol—UGT1A1—renal system—kidney cancer	0.001	0.0225	CbGeAlD
Propofol—UGT1A1—kidney—kidney cancer	0.000968	0.0217	CbGeAlD
Propofol—SCN2A—cortex of kidney—kidney cancer	0.000905	0.0203	CbGeAlD
Propofol—GABRA2—cortex of kidney—kidney cancer	0.000702	0.0158	CbGeAlD
Propofol—CYP1B1—nephron tubule—kidney cancer	0.00068	0.0153	CbGeAlD
Propofol—CYP1B1—renal system—kidney cancer	0.000619	0.0139	CbGeAlD
Propofol—CYP1B1—kidney—kidney cancer	0.000598	0.0134	CbGeAlD
Propofol—CYP1B1—cortex of kidney—kidney cancer	0.000582	0.0131	CbGeAlD
Propofol—GABRB3—gonad—kidney cancer	0.000562	0.0126	CbGeAlD
Propofol—CYP1B1—gonad—kidney cancer	0.000555	0.0125	CbGeAlD
Propofol—CYP2C8—renal system—kidney cancer	0.000474	0.0106	CbGeAlD
Propofol—CYP2B6—nephron tubule—kidney cancer	0.000467	0.0105	CbGeAlD
Propofol—CYP2C8—kidney—kidney cancer	0.000458	0.0103	CbGeAlD
Propofol—CYP1A2—renal system—kidney cancer	0.000443	0.00996	CbGeAlD
Propofol—CYP2E1—nephron tubule—kidney cancer	0.000439	0.00985	CbGeAlD
Propofol—CYP1A1—renal system—kidney cancer	0.000437	0.00982	CbGeAlD
Propofol—CYP2B6—renal system—kidney cancer	0.000425	0.00954	CbGeAlD
Propofol—CYP1A1—kidney—kidney cancer	0.000423	0.00949	CbGeAlD
Propofol—CYP2B6—kidney—kidney cancer	0.000411	0.00923	CbGeAlD
Propofol—CYP2E1—renal system—kidney cancer	0.000399	0.00896	CbGeAlD
Propofol—CYP1A1—cardiac atrium—kidney cancer	0.000392	0.00879	CbGeAlD
Propofol—CYP2E1—kidney—kidney cancer	0.000385	0.00866	CbGeAlD
Propofol—CYP2B6—gonad—kidney cancer	0.000381	0.00856	CbGeAlD
Propofol—CYP2E1—cortex of kidney—kidney cancer	0.000375	0.00843	CbGeAlD
Propofol—CYP3A4—renal system—kidney cancer	0.000321	0.00721	CbGeAlD
Propofol—CYP2D6—renal system—kidney cancer	0.000316	0.00709	CbGeAlD
Propofol—CYP3A4—kidney—kidney cancer	0.00031	0.00697	CbGeAlD
Propofol—CYP2D6—kidney—kidney cancer	0.000305	0.00686	CbGeAlD
Propofol—Pruritus—Everolimus—kidney cancer	0.000127	0.000837	CcSEcCtD
Propofol—Oedema—Vincristine—kidney cancer	0.000127	0.000836	CcSEcCtD
Propofol—Anaphylactic shock—Vincristine—kidney cancer	0.000127	0.000836	CcSEcCtD
Propofol—Arrhythmia—Paclitaxel—kidney cancer	0.000127	0.000835	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—kidney cancer	0.000126	0.00083	CcSEcCtD
Propofol—Myalgia—Gemcitabine—kidney cancer	0.000126	0.000828	CcSEcCtD
Propofol—Chest pain—Gemcitabine—kidney cancer	0.000126	0.000828	CcSEcCtD
Propofol—Asthenia—Erlotinib—kidney cancer	0.000125	0.000819	CcSEcCtD
Propofol—Urticaria—Sorafenib—kidney cancer	0.000124	0.000816	CcSEcCtD
Propofol—Erythema—Paclitaxel—kidney cancer	0.000124	0.000814	CcSEcCtD
Propofol—Diarrhoea—Vinblastine—kidney cancer	0.000124	0.000813	CcSEcCtD
Propofol—Abdominal pain—Sorafenib—kidney cancer	0.000124	0.000812	CcSEcCtD
Propofol—Body temperature increased—Sorafenib—kidney cancer	0.000124	0.000812	CcSEcCtD
Propofol—Diarrhoea—Everolimus—kidney cancer	0.000123	0.00081	CcSEcCtD
Propofol—Hyperhidrosis—Vincristine—kidney cancer	0.000123	0.000808	CcSEcCtD
Propofol—Pruritus—Erlotinib—kidney cancer	0.000123	0.000808	CcSEcCtD
Propofol—Fatigue—Dactinomycin—kidney cancer	0.000123	0.000807	CcSEcCtD
Propofol—Pain—Dactinomycin—kidney cancer	0.000122	0.0008	CcSEcCtD
Propofol—Dysgeusia—Paclitaxel—kidney cancer	0.000121	0.000797	CcSEcCtD
Propofol—Anaphylactic shock—Gemcitabine—kidney cancer	0.000121	0.000793	CcSEcCtD
Propofol—Oedema—Gemcitabine—kidney cancer	0.000121	0.000793	CcSEcCtD
Propofol—Eye pain—Doxorubicin—kidney cancer	0.000121	0.000792	CcSEcCtD
Propofol—Dizziness—Vinblastine—kidney cancer	0.00012	0.000786	CcSEcCtD
Propofol—Dizziness—Everolimus—kidney cancer	0.000119	0.000783	CcSEcCtD
Propofol—Muscle spasms—Paclitaxel—kidney cancer	0.000119	0.000782	CcSEcCtD
Propofol—Body temperature increased—Sunitinib—kidney cancer	0.000119	0.000782	CcSEcCtD
Propofol—Abdominal pain—Sunitinib—kidney cancer	0.000119	0.000782	CcSEcCtD
Propofol—Diarrhoea—Erlotinib—kidney cancer	0.000119	0.000781	CcSEcCtD
Propofol—Hypotension—Vincristine—kidney cancer	0.000119	0.000781	CcSEcCtD
Propofol—Bradycardia—Capecitabine—kidney cancer	0.000119	0.000781	CcSEcCtD
Propofol—Feeling abnormal—Dactinomycin—kidney cancer	0.000117	0.000771	CcSEcCtD
Propofol—Haemoglobin—Capecitabine—kidney cancer	0.000117	0.000771	CcSEcCtD
Propofol—Haemorrhage—Capecitabine—kidney cancer	0.000117	0.000767	CcSEcCtD
Propofol—Hyperhidrosis—Gemcitabine—kidney cancer	0.000117	0.000767	CcSEcCtD
Propofol—Tremor—Paclitaxel—kidney cancer	0.000116	0.000763	CcSEcCtD
Propofol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000116	0.000762	CcSEcCtD
Propofol—Pharyngitis—Capecitabine—kidney cancer	0.000116	0.000761	CcSEcCtD
Propofol—Insomnia—Vincristine—kidney cancer	0.000115	0.000756	CcSEcCtD
Propofol—Vomiting—Vinblastine—kidney cancer	0.000115	0.000756	CcSEcCtD
Propofol—Dizziness—Erlotinib—kidney cancer	0.000115	0.000755	CcSEcCtD
Propofol—Vomiting—Everolimus—kidney cancer	0.000115	0.000753	CcSEcCtD
Propofol—Paraesthesia—Vincristine—kidney cancer	0.000114	0.000751	CcSEcCtD
Propofol—Agitation—Paclitaxel—kidney cancer	0.000114	0.000748	CcSEcCtD
Propofol—Rash—Everolimus—kidney cancer	0.000114	0.000746	CcSEcCtD
Propofol—Dermatitis—Everolimus—kidney cancer	0.000113	0.000746	CcSEcCtD
Propofol—Headache—Vinblastine—kidney cancer	0.000113	0.000744	CcSEcCtD
Propofol—Angioedema—Paclitaxel—kidney cancer	0.000113	0.000744	CcSEcCtD
Propofol—Headache—Everolimus—kidney cancer	0.000113	0.000742	CcSEcCtD
Propofol—Hypotension—Gemcitabine—kidney cancer	0.000113	0.000741	CcSEcCtD
Propofol—Body temperature increased—Dactinomycin—kidney cancer	0.000113	0.00074	CcSEcCtD
Propofol—Abdominal pain—Dactinomycin—kidney cancer	0.000113	0.00074	CcSEcCtD
Propofol—Visual impairment—Capecitabine—kidney cancer	0.000113	0.000739	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000112	0.000739	CcSEcCtD
Propofol—Asthenia—Sorafenib—kidney cancer	0.000112	0.000737	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—kidney cancer	0.000111	0.000733	CcSEcCtD
Propofol—Syncope—Paclitaxel—kidney cancer	0.000111	0.00073	CcSEcCtD
Propofol—Pruritus—Sorafenib—kidney cancer	0.000111	0.000727	CcSEcCtD
Propofol—Vomiting—Erlotinib—kidney cancer	0.000111	0.000726	CcSEcCtD
Propofol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00011	0.000723	CcSEcCtD
Propofol—Fatigue—Vincristine—kidney cancer	0.00011	0.000721	CcSEcCtD
Propofol—Rash—Erlotinib—kidney cancer	0.00011	0.00072	CcSEcCtD
Propofol—Dermatitis—Erlotinib—kidney cancer	0.00011	0.000719	CcSEcCtD
Propofol—Insomnia—Gemcitabine—kidney cancer	0.000109	0.000718	CcSEcCtD
Propofol—Headache—Erlotinib—kidney cancer	0.000109	0.000716	CcSEcCtD
Propofol—Tinnitus—Capecitabine—kidney cancer	0.000109	0.000715	CcSEcCtD
Propofol—Loss of consciousness—Paclitaxel—kidney cancer	0.000109	0.000715	CcSEcCtD
Propofol—Pain—Vincristine—kidney cancer	0.000109	0.000715	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—kidney cancer	0.000109	0.000715	CcSEcCtD
Propofol—Diplopia—Doxorubicin—kidney cancer	0.000109	0.000715	CcSEcCtD
Propofol—Paraesthesia—Gemcitabine—kidney cancer	0.000108	0.000712	CcSEcCtD
Propofol—Flushing—Capecitabine—kidney cancer	0.000108	0.000712	CcSEcCtD
Propofol—Cough—Paclitaxel—kidney cancer	0.000108	0.00071	CcSEcCtD
Propofol—Asthenia—Sunitinib—kidney cancer	0.000108	0.000709	CcSEcCtD
Propofol—Dyspnoea—Gemcitabine—kidney cancer	0.000108	0.000707	CcSEcCtD
Propofol—Nausea—Vinblastine—kidney cancer	0.000107	0.000706	CcSEcCtD
Propofol—Somnolence—Gemcitabine—kidney cancer	0.000107	0.000705	CcSEcCtD
Propofol—Convulsion—Paclitaxel—kidney cancer	0.000107	0.000705	CcSEcCtD
Propofol—Affect lability—Doxorubicin—kidney cancer	0.000107	0.000704	CcSEcCtD
Propofol—Nausea—Everolimus—kidney cancer	0.000107	0.000703	CcSEcCtD
Propofol—Diarrhoea—Sorafenib—kidney cancer	0.000107	0.000703	CcSEcCtD
Propofol—Hypertension—Paclitaxel—kidney cancer	0.000107	0.000703	CcSEcCtD
Propofol—Pruritus—Sunitinib—kidney cancer	0.000106	0.0007	CcSEcCtD
Propofol—Chest pain—Paclitaxel—kidney cancer	0.000105	0.000693	CcSEcCtD
Propofol—Myalgia—Paclitaxel—kidney cancer	0.000105	0.000693	CcSEcCtD
Propofol—Anxiety—Paclitaxel—kidney cancer	0.000105	0.00069	CcSEcCtD
Propofol—Chills—Capecitabine—kidney cancer	0.000105	0.000688	CcSEcCtD
Propofol—Arrhythmia—Capecitabine—kidney cancer	0.000104	0.000685	CcSEcCtD
Propofol—Fatigue—Gemcitabine—kidney cancer	0.000104	0.000684	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—kidney cancer	0.000103	0.00068	CcSEcCtD
Propofol—Dizziness—Sorafenib—kidney cancer	0.000103	0.000679	CcSEcCtD
Propofol—Pain—Gemcitabine—kidney cancer	0.000103	0.000678	CcSEcCtD
Propofol—Nausea—Erlotinib—kidney cancer	0.000103	0.000678	CcSEcCtD
Propofol—Dry mouth—Paclitaxel—kidney cancer	0.000103	0.000678	CcSEcCtD
Propofol—Mood swings—Doxorubicin—kidney cancer	0.000103	0.000677	CcSEcCtD
Propofol—Diarrhoea—Sunitinib—kidney cancer	0.000103	0.000676	CcSEcCtD
Propofol—Asthenia—Dactinomycin—kidney cancer	0.000102	0.000672	CcSEcCtD
Propofol—Confusional state—Paclitaxel—kidney cancer	0.000102	0.00067	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—kidney cancer	0.000102	0.00067	CcSEcCtD
Propofol—Erythema—Capecitabine—kidney cancer	0.000102	0.000668	CcSEcCtD
Propofol—Dehydration—Doxorubicin—kidney cancer	0.000101	0.000665	CcSEcCtD
Propofol—Anaphylactic shock—Paclitaxel—kidney cancer	0.000101	0.000664	CcSEcCtD
Propofol—Oedema—Paclitaxel—kidney cancer	0.000101	0.000664	CcSEcCtD
Propofol—Body temperature increased—Vincristine—kidney cancer	0.000101	0.000661	CcSEcCtD
Propofol—Abdominal pain—Vincristine—kidney cancer	0.000101	0.000661	CcSEcCtD
Propofol—Dysgeusia—Capecitabine—kidney cancer	9.95e-05	0.000654	CcSEcCtD
Propofol—Dizziness—Sunitinib—kidney cancer	9.95e-05	0.000654	CcSEcCtD
Propofol—Feeling abnormal—Gemcitabine—kidney cancer	9.95e-05	0.000654	CcSEcCtD
Propofol—Shock—Paclitaxel—kidney cancer	9.95e-05	0.000653	CcSEcCtD
Propofol—Vomiting—Sorafenib—kidney cancer	9.94e-05	0.000653	CcSEcCtD
Propofol—Tachycardia—Paclitaxel—kidney cancer	9.87e-05	0.000648	CcSEcCtD
Propofol—Rash—Sorafenib—kidney cancer	9.86e-05	0.000648	CcSEcCtD
Propofol—Dermatitis—Sorafenib—kidney cancer	9.85e-05	0.000647	CcSEcCtD
Propofol—Headache—Sorafenib—kidney cancer	9.8e-05	0.000644	CcSEcCtD
Propofol—Muscle spasms—Capecitabine—kidney cancer	9.77e-05	0.000642	CcSEcCtD
Propofol—Hyperhidrosis—Paclitaxel—kidney cancer	9.77e-05	0.000642	CcSEcCtD
Propofol—Diarrhoea—Dactinomycin—kidney cancer	9.75e-05	0.00064	CcSEcCtD
Propofol—Vomiting—Sunitinib—kidney cancer	9.57e-05	0.000629	CcSEcCtD
Propofol—Body temperature increased—Gemcitabine—kidney cancer	9.55e-05	0.000627	CcSEcCtD
Propofol—Tremor—Capecitabine—kidney cancer	9.52e-05	0.000626	CcSEcCtD
Propofol—Rash—Sunitinib—kidney cancer	9.49e-05	0.000623	CcSEcCtD
Propofol—Dermatitis—Sunitinib—kidney cancer	9.48e-05	0.000623	CcSEcCtD
Propofol—Hypotension—Paclitaxel—kidney cancer	9.45e-05	0.000621	CcSEcCtD
Propofol—Headache—Sunitinib—kidney cancer	9.43e-05	0.000619	CcSEcCtD
Propofol—Nausea—Sorafenib—kidney cancer	9.29e-05	0.00061	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—kidney cancer	9.22e-05	0.000606	CcSEcCtD
Propofol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.21e-05	0.000605	CcSEcCtD
Propofol—Insomnia—Paclitaxel—kidney cancer	9.14e-05	0.000601	CcSEcCtD
Propofol—Asthenia—Vincristine—kidney cancer	9.13e-05	0.0006	CcSEcCtD
Propofol—Syncope—Capecitabine—kidney cancer	9.12e-05	0.000599	CcSEcCtD
Propofol—Paraesthesia—Paclitaxel—kidney cancer	9.08e-05	0.000596	CcSEcCtD
Propofol—Vomiting—Dactinomycin—kidney cancer	9.06e-05	0.000595	CcSEcCtD
Propofol—Dyspnoea—Paclitaxel—kidney cancer	9.01e-05	0.000592	CcSEcCtD
Propofol—Somnolence—Paclitaxel—kidney cancer	8.99e-05	0.00059	CcSEcCtD
Propofol—Rash—Dactinomycin—kidney cancer	8.98e-05	0.00059	CcSEcCtD
Propofol—Nausea—Sunitinib—kidney cancer	8.94e-05	0.000587	CcSEcCtD
Propofol—Loss of consciousness—Capecitabine—kidney cancer	8.93e-05	0.000587	CcSEcCtD
Propofol—Cough—Capecitabine—kidney cancer	8.87e-05	0.000583	CcSEcCtD
Propofol—Hypertension—Capecitabine—kidney cancer	8.78e-05	0.000577	CcSEcCtD
Propofol—Fatigue—Paclitaxel—kidney cancer	8.72e-05	0.000573	CcSEcCtD
Propofol—Diarrhoea—Vincristine—kidney cancer	8.71e-05	0.000572	CcSEcCtD
Propofol—Asthenia—Gemcitabine—kidney cancer	8.66e-05	0.000569	CcSEcCtD
Propofol—Myalgia—Capecitabine—kidney cancer	8.65e-05	0.000569	CcSEcCtD
Propofol—Chest pain—Capecitabine—kidney cancer	8.65e-05	0.000569	CcSEcCtD
Propofol—Pain—Paclitaxel—kidney cancer	8.65e-05	0.000568	CcSEcCtD
Propofol—Anxiety—Capecitabine—kidney cancer	8.62e-05	0.000567	CcSEcCtD
Propofol—Pruritus—Gemcitabine—kidney cancer	8.54e-05	0.000561	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—kidney cancer	8.48e-05	0.000557	CcSEcCtD
Propofol—Dry mouth—Capecitabine—kidney cancer	8.46e-05	0.000556	CcSEcCtD
Propofol—Nausea—Dactinomycin—kidney cancer	8.46e-05	0.000556	CcSEcCtD
Propofol—Dizziness—Vincristine—kidney cancer	8.42e-05	0.000553	CcSEcCtD
Propofol—Confusional state—Capecitabine—kidney cancer	8.37e-05	0.00055	CcSEcCtD
Propofol—Feeling abnormal—Paclitaxel—kidney cancer	8.33e-05	0.000547	CcSEcCtD
Propofol—Oedema—Capecitabine—kidney cancer	8.3e-05	0.000545	CcSEcCtD
Propofol—Diarrhoea—Gemcitabine—kidney cancer	8.26e-05	0.000543	CcSEcCtD
Propofol—Renal failure—Doxorubicin—kidney cancer	8.24e-05	0.000542	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—kidney cancer	8.22e-05	0.00054	CcSEcCtD
Propofol—Shock—Capecitabine—kidney cancer	8.16e-05	0.000536	CcSEcCtD
Propofol—Tachycardia—Capecitabine—kidney cancer	8.1e-05	0.000532	CcSEcCtD
Propofol—Vomiting—Vincristine—kidney cancer	8.09e-05	0.000532	CcSEcCtD
Propofol—Urticaria—Paclitaxel—kidney cancer	8.03e-05	0.000528	CcSEcCtD
Propofol—Rash—Vincristine—kidney cancer	8.03e-05	0.000527	CcSEcCtD
Propofol—Hyperhidrosis—Capecitabine—kidney cancer	8.02e-05	0.000527	CcSEcCtD
Propofol—Dermatitis—Vincristine—kidney cancer	8.02e-05	0.000527	CcSEcCtD
Propofol—Body temperature increased—Paclitaxel—kidney cancer	7.99e-05	0.000525	CcSEcCtD
Propofol—Abdominal pain—Paclitaxel—kidney cancer	7.99e-05	0.000525	CcSEcCtD
Propofol—Headache—Vincristine—kidney cancer	7.97e-05	0.000524	CcSEcCtD
Propofol—Hypotension—Capecitabine—kidney cancer	7.75e-05	0.000509	CcSEcCtD
Propofol—Vomiting—Gemcitabine—kidney cancer	7.68e-05	0.000504	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—kidney cancer	7.66e-05	0.000503	CcSEcCtD
Propofol—Rash—Gemcitabine—kidney cancer	7.61e-05	0.0005	CcSEcCtD
Propofol—Dermatitis—Gemcitabine—kidney cancer	7.61e-05	0.0005	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—kidney cancer	7.57e-05	0.000497	CcSEcCtD
Propofol—Headache—Gemcitabine—kidney cancer	7.56e-05	0.000497	CcSEcCtD
Propofol—Nausea—Vincristine—kidney cancer	7.56e-05	0.000497	CcSEcCtD
Propofol—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.56e-05	0.000497	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—kidney cancer	7.53e-05	0.000495	CcSEcCtD
Propofol—Insomnia—Capecitabine—kidney cancer	7.5e-05	0.000493	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—kidney cancer	7.47e-05	0.000491	CcSEcCtD
Propofol—Paraesthesia—Capecitabine—kidney cancer	7.45e-05	0.000489	CcSEcCtD
Propofol—Dyspnoea—Capecitabine—kidney cancer	7.4e-05	0.000486	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—kidney cancer	7.25e-05	0.000477	CcSEcCtD
Propofol—Asthenia—Paclitaxel—kidney cancer	7.25e-05	0.000477	CcSEcCtD
Propofol—Nausea—Gemcitabine—kidney cancer	7.17e-05	0.000471	CcSEcCtD
Propofol—Fatigue—Capecitabine—kidney cancer	7.15e-05	0.00047	CcSEcCtD
Propofol—Pruritus—Paclitaxel—kidney cancer	7.15e-05	0.00047	CcSEcCtD
Propofol—Pain—Capecitabine—kidney cancer	7.09e-05	0.000466	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—kidney cancer	7.02e-05	0.000461	CcSEcCtD
Propofol—Flushing—Doxorubicin—kidney cancer	6.99e-05	0.000459	CcSEcCtD
Propofol—Diarrhoea—Paclitaxel—kidney cancer	6.92e-05	0.000454	CcSEcCtD
Propofol—Feeling abnormal—Capecitabine—kidney cancer	6.84e-05	0.000449	CcSEcCtD
Propofol—Chills—Doxorubicin—kidney cancer	6.75e-05	0.000444	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—kidney cancer	6.72e-05	0.000442	CcSEcCtD
Propofol—Dizziness—Paclitaxel—kidney cancer	6.69e-05	0.000439	CcSEcCtD
Propofol—Urticaria—Capecitabine—kidney cancer	6.59e-05	0.000433	CcSEcCtD
Propofol—Body temperature increased—Capecitabine—kidney cancer	6.56e-05	0.000431	CcSEcCtD
Propofol—Abdominal pain—Capecitabine—kidney cancer	6.56e-05	0.000431	CcSEcCtD
Propofol—Erythema—Doxorubicin—kidney cancer	6.55e-05	0.000431	CcSEcCtD
Propofol—Vomiting—Paclitaxel—kidney cancer	6.43e-05	0.000422	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—kidney cancer	6.42e-05	0.000422	CcSEcCtD
Propofol—Rash—Paclitaxel—kidney cancer	6.37e-05	0.000419	CcSEcCtD
Propofol—Dermatitis—Paclitaxel—kidney cancer	6.37e-05	0.000418	CcSEcCtD
Propofol—Headache—Paclitaxel—kidney cancer	6.33e-05	0.000416	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—kidney cancer	6.3e-05	0.000414	CcSEcCtD
Propofol—Agitation—Doxorubicin—kidney cancer	6.02e-05	0.000396	CcSEcCtD
Propofol—Nausea—Paclitaxel—kidney cancer	6.01e-05	0.000395	CcSEcCtD
Propofol—Asthenia—Capecitabine—kidney cancer	5.95e-05	0.000391	CcSEcCtD
Propofol—Syncope—Doxorubicin—kidney cancer	5.88e-05	0.000386	CcSEcCtD
Propofol—Pruritus—Capecitabine—kidney cancer	5.87e-05	0.000386	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—kidney cancer	5.76e-05	0.000378	CcSEcCtD
Propofol—Cough—Doxorubicin—kidney cancer	5.72e-05	0.000376	CcSEcCtD
Propofol—Convulsion—Doxorubicin—kidney cancer	5.68e-05	0.000373	CcSEcCtD
Propofol—Diarrhoea—Capecitabine—kidney cancer	5.68e-05	0.000373	CcSEcCtD
Propofol—Hypertension—Doxorubicin—kidney cancer	5.66e-05	0.000372	CcSEcCtD
Propofol—Chest pain—Doxorubicin—kidney cancer	5.58e-05	0.000367	CcSEcCtD
Propofol—Myalgia—Doxorubicin—kidney cancer	5.58e-05	0.000367	CcSEcCtD
Propofol—Anxiety—Doxorubicin—kidney cancer	5.56e-05	0.000365	CcSEcCtD
Propofol—Dizziness—Capecitabine—kidney cancer	5.49e-05	0.00036	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—kidney cancer	5.46e-05	0.000358	CcSEcCtD
Propofol—Confusional state—Doxorubicin—kidney cancer	5.39e-05	0.000354	CcSEcCtD
Propofol—Oedema—Doxorubicin—kidney cancer	5.35e-05	0.000351	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—kidney cancer	5.35e-05	0.000351	CcSEcCtD
Propofol—Vomiting—Capecitabine—kidney cancer	5.28e-05	0.000347	CcSEcCtD
Propofol—Shock—Doxorubicin—kidney cancer	5.26e-05	0.000346	CcSEcCtD
Propofol—Rash—Capecitabine—kidney cancer	5.23e-05	0.000344	CcSEcCtD
Propofol—Dermatitis—Capecitabine—kidney cancer	5.23e-05	0.000343	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—kidney cancer	5.22e-05	0.000343	CcSEcCtD
Propofol—Headache—Capecitabine—kidney cancer	5.2e-05	0.000341	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—kidney cancer	5.17e-05	0.00034	CcSEcCtD
Propofol—Hypotension—Doxorubicin—kidney cancer	5e-05	0.000328	CcSEcCtD
Propofol—Nausea—Capecitabine—kidney cancer	4.93e-05	0.000324	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.87e-05	0.00032	CcSEcCtD
Propofol—Insomnia—Doxorubicin—kidney cancer	4.84e-05	0.000318	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—kidney cancer	4.8e-05	0.000316	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—kidney cancer	4.77e-05	0.000313	CcSEcCtD
Propofol—Somnolence—Doxorubicin—kidney cancer	4.75e-05	0.000312	CcSEcCtD
Propofol—Fatigue—Doxorubicin—kidney cancer	4.61e-05	0.000303	CcSEcCtD
Propofol—Pain—Doxorubicin—kidney cancer	4.57e-05	0.0003	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—kidney cancer	4.41e-05	0.00029	CcSEcCtD
Propofol—Urticaria—Doxorubicin—kidney cancer	4.25e-05	0.000279	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—kidney cancer	4.23e-05	0.000278	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—kidney cancer	4.23e-05	0.000278	CcSEcCtD
Propofol—Asthenia—Doxorubicin—kidney cancer	3.84e-05	0.000252	CcSEcCtD
Propofol—Pruritus—Doxorubicin—kidney cancer	3.78e-05	0.000249	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—kidney cancer	3.66e-05	0.00024	CcSEcCtD
Propofol—Dizziness—Doxorubicin—kidney cancer	3.54e-05	0.000232	CcSEcCtD
Propofol—Vomiting—Doxorubicin—kidney cancer	3.4e-05	0.000223	CcSEcCtD
Propofol—Rash—Doxorubicin—kidney cancer	3.37e-05	0.000222	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—kidney cancer	3.37e-05	0.000221	CcSEcCtD
Propofol—Headache—Doxorubicin—kidney cancer	3.35e-05	0.00022	CcSEcCtD
Propofol—Nausea—Doxorubicin—kidney cancer	3.18e-05	0.000209	CcSEcCtD
Propofol—UGT1A9—Metabolism—CYP1A1—kidney cancer	7.34e-06	8.25e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CA9—kidney cancer	7.29e-06	8.2e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PGK1—kidney cancer	7.26e-06	8.17e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A3—kidney cancer	7.26e-06	8.17e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CA9—kidney cancer	7.22e-06	8.13e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTM1—kidney cancer	7.22e-06	8.12e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SCARB1—kidney cancer	7.15e-06	8.05e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—LDHB—kidney cancer	7.12e-06	8.01e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS1—kidney cancer	7.08e-06	7.97e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.06e-06	7.94e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.05e-06	7.94e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ITPR2—kidney cancer	7.02e-06	7.89e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SCARB1—kidney cancer	7.01e-06	7.88e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ACHE—kidney cancer	6.98e-06	7.85e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTT1—kidney cancer	6.98e-06	7.85e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—ITPR2—kidney cancer	6.98e-06	7.85e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PSMD7—kidney cancer	6.94e-06	7.81e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS1—kidney cancer	6.94e-06	7.8e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—POMC—kidney cancer	6.92e-06	7.79e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—FH—kidney cancer	6.87e-06	7.73e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APRT—kidney cancer	6.87e-06	7.73e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP1A1—kidney cancer	6.84e-06	7.7e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PSMD7—kidney cancer	6.8e-06	7.65e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CRABP1—kidney cancer	6.74e-06	7.58e-05	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.72e-06	7.57e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SCARB1—kidney cancer	6.61e-06	7.43e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—BCHE—kidney cancer	6.58e-06	7.41e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS1—kidney cancer	6.54e-06	7.36e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC5A5—kidney cancer	6.5e-06	7.32e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTP1—kidney cancer	6.49e-06	7.3e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.47e-06	7.28e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GPC3—kidney cancer	6.46e-06	7.27e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—BCHE—kidney cancer	6.45e-06	7.25e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.43e-06	7.24e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PSMD7—kidney cancer	6.41e-06	7.22e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTT1—kidney cancer	6.4e-06	7.2e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ACHE—kidney cancer	6.4e-06	7.2e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC5A5—kidney cancer	6.37e-06	7.17e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—ACHE—kidney cancer	6.36e-06	7.16e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTT1—kidney cancer	6.36e-06	7.16e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CA2—kidney cancer	6.29e-06	7.07e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC2A1—kidney cancer	6.28e-06	7.07e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ITPR2—kidney cancer	6.26e-06	7.05e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CRABP1—kidney cancer	6.2e-06	6.97e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CA9—kidney cancer	6.17e-06	6.95e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC2A1—kidney cancer	6.15e-06	6.92e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ABCB1—kidney cancer	6.15e-06	6.91e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CRABP1—kidney cancer	6.14e-06	6.91e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALAD—kidney cancer	6.13e-06	6.89e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—BCHE—kidney cancer	6.08e-06	6.84e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SCARB1—kidney cancer	6.06e-06	6.81e-05	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—kidney cancer	6.05e-06	6.81e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.03e-06	6.79e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.03e-06	6.78e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—SCARB1—kidney cancer	6.02e-06	6.78e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC5A5—kidney cancer	6e-06	6.76e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS1—kidney cancer	5.99e-06	6.75e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.98e-06	6.73e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTM1—kidney cancer	5.97e-06	6.71e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS1—kidney cancer	5.96e-06	6.71e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PSMD7—kidney cancer	5.88e-06	6.61e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PSMD7—kidney cancer	5.85e-06	6.58e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.84e-06	6.58e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—RAF1—kidney cancer	5.82e-06	6.55e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC2A1—kidney cancer	5.8e-06	6.53e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.77e-06	6.5e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ITPR2—kidney cancer	5.76e-06	6.48e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTT1—kidney cancer	5.71e-06	6.43e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ACHE—kidney cancer	5.71e-06	6.43e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ITPR2—kidney cancer	5.71e-06	6.42e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP1A1—kidney cancer	5.66e-06	6.36e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.63e-06	6.33e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.62e-06	6.32e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.6e-06	6.3e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PGK1—kidney cancer	5.6e-06	6.3e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—BCHE—kidney cancer	5.57e-06	6.27e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—BCHE—kidney cancer	5.54e-06	6.24e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—kidney cancer	5.52e-06	6.21e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.51e-06	6.19e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—LDHB—kidney cancer	5.49e-06	6.18e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC5A5—kidney cancer	5.47e-06	6.16e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—POMC—kidney cancer	5.47e-06	6.15e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—POMC—kidney cancer	5.47e-06	6.15e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SCARB1—kidney cancer	5.41e-06	6.08e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS1—kidney cancer	5.35e-06	6.02e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.32e-06	5.98e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC2A1—kidney cancer	5.29e-06	5.95e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.26e-06	5.92e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ACHE—kidney cancer	5.25e-06	5.91e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTT1—kidney cancer	5.25e-06	5.91e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CRABP1—kidney cancer	5.25e-06	5.91e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PSMD7—kidney cancer	5.25e-06	5.9e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—kidney cancer	5.24e-06	5.89e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—kidney cancer	5.22e-06	5.88e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ACHE—kidney cancer	5.21e-06	5.86e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTT1—kidney cancer	5.21e-06	5.86e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.16e-06	5.8e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—kidney cancer	5.13e-06	5.77e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.13e-06	5.77e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—POMC—kidney cancer	5.1e-06	5.74e-05	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	5.04e-06	5.67e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—BCHE—kidney cancer	4.97e-06	5.6e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SCARB1—kidney cancer	4.97e-06	5.59e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ABCB1—kidney cancer	4.96e-06	5.58e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SCARB1—kidney cancer	4.93e-06	5.55e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS1—kidney cancer	4.92e-06	5.54e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.91e-06	5.53e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.91e-06	5.52e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ITPR2—kidney cancer	4.88e-06	5.49e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS1—kidney cancer	4.88e-06	5.49e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ABCB1—kidney cancer	4.86e-06	5.46e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—kidney cancer	4.84e-06	5.44e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PSMD7—kidney cancer	4.83e-06	5.43e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTM1—kidney cancer	4.81e-06	5.42e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—kidney cancer	4.81e-06	5.42e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PSMD7—kidney cancer	4.78e-06	5.38e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CA9—kidney cancer	4.76e-06	5.36e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.75e-06	5.34e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTM1—kidney cancer	4.71e-06	5.3e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.6e-06	5.18e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ABCB1—kidney cancer	4.58e-06	5.15e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—BCHE—kidney cancer	4.58e-06	5.15e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP1A1—kidney cancer	4.56e-06	5.13e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—BCHE—kidney cancer	4.54e-06	5.1e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.52e-06	5.09e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.5e-06	5.06e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.5e-06	5.06e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.48e-06	5.04e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTT1—kidney cancer	4.45e-06	5.01e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ACHE—kidney cancer	4.45e-06	5.01e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTM1—kidney cancer	4.44e-06	5e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—kidney cancer	4.44e-06	4.99e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—kidney cancer	4.43e-06	4.99e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—kidney cancer	4.41e-06	4.96e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.36e-06	4.91e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—kidney cancer	4.36e-06	4.91e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—kidney cancer	4.36e-06	4.91e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.33e-06	4.87e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—POMC—kidney cancer	4.22e-06	4.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SCARB1—kidney cancer	4.21e-06	4.74e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.2e-06	4.72e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK3—kidney cancer	4.2e-06	4.72e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ABCB1—kidney cancer	4.2e-06	4.72e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—ABCB1—kidney cancer	4.17e-06	4.7e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS1—kidney cancer	4.17e-06	4.69e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PSMD7—kidney cancer	4.09e-06	4.6e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTM1—kidney cancer	4.08e-06	4.59e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—kidney cancer	4.07e-06	4.58e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTM1—kidney cancer	4.05e-06	4.56e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CRABP1—kidney cancer	4.05e-06	4.56e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.02e-06	4.52e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK1—kidney cancer	3.99e-06	4.49e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—kidney cancer	3.96e-06	4.45e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—BCHE—kidney cancer	3.88e-06	4.36e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.86e-06	4.35e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1A1—kidney cancer	3.84e-06	4.32e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.83e-06	4.31e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—kidney cancer	3.8e-06	4.28e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—kidney cancer	3.8e-06	4.28e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—kidney cancer	3.77e-06	4.25e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ITPR2—kidney cancer	3.77e-06	4.24e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ABCB1—kidney cancer	3.75e-06	4.22e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.7e-06	4.16e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.66e-06	4.12e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—kidney cancer	3.64e-06	4.1e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTM1—kidney cancer	3.64e-06	4.09e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—kidney cancer	3.61e-06	4.06e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.59e-06	4.04e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—kidney cancer	3.55e-06	3.99e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—kidney cancer	3.47e-06	3.9e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.46e-06	3.9e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.45e-06	3.88e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ABCB1—kidney cancer	3.45e-06	3.88e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTT1—kidney cancer	3.43e-06	3.86e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ACHE—kidney cancer	3.43e-06	3.86e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ABCB1—kidney cancer	3.42e-06	3.84e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—POMC—kidney cancer	3.4e-06	3.83e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—kidney cancer	3.4e-06	3.82e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—kidney cancer	3.36e-06	3.78e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—kidney cancer	3.35e-06	3.77e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTM1—kidney cancer	3.35e-06	3.76e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—POMC—kidney cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTM1—kidney cancer	3.32e-06	3.73e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SCARB1—kidney cancer	3.25e-06	3.66e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS1—kidney cancer	3.22e-06	3.62e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.17e-06	3.57e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.17e-06	3.57e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.16e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PSMD7—kidney cancer	3.16e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.14e-06	3.54e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—POMC—kidney cancer	3.14e-06	3.53e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-06	3.52e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—kidney cancer	3.08e-06	3.47e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—BCHE—kidney cancer	2.99e-06	3.37e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.95e-06	3.32e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—kidney cancer	2.93e-06	3.3e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ABCB1—kidney cancer	2.92e-06	3.28e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—POMC—kidney cancer	2.88e-06	3.24e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—POMC—kidney cancer	2.86e-06	3.22e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.85e-06	3.21e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTM1—kidney cancer	2.83e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.83e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—kidney cancer	2.71e-06	3.05e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.69e-06	3.02e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—kidney cancer	2.68e-06	3.02e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—kidney cancer	2.68e-06	3.02e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—kidney cancer	2.66e-06	2.99e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.58e-06	2.91e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—POMC—kidney cancer	2.57e-06	2.89e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—kidney cancer	2.51e-06	2.82e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—kidney cancer	2.5e-06	2.82e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—kidney cancer	2.38e-06	2.68e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—kidney cancer	2.37e-06	2.66e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—POMC—kidney cancer	2.36e-06	2.66e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—POMC—kidney cancer	2.34e-06	2.64e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—kidney cancer	2.32e-06	2.61e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—kidney cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—kidney cancer	2.28e-06	2.57e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ABCB1—kidney cancer	2.25e-06	2.54e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-06	2.48e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTM1—kidney cancer	2.19e-06	2.46e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—kidney cancer	2.19e-06	2.46e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.07e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—kidney cancer	2.07e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—kidney cancer	2.05e-06	2.31e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—kidney cancer	2e-06	2.25e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—POMC—kidney cancer	2e-06	2.25e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—kidney cancer	1.99e-06	2.24e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—kidney cancer	1.89e-06	2.12e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—kidney cancer	1.87e-06	2.1e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—kidney cancer	1.79e-06	2.01e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.67e-06	1.88e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—kidney cancer	1.64e-06	1.85e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.64e-06	1.84e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—kidney cancer	1.63e-06	1.83e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—kidney cancer	1.6e-06	1.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—POMC—kidney cancer	1.55e-06	1.74e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.54e-06	1.73e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.41e-06	1.59e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—kidney cancer	1.41e-06	1.58e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—kidney cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—kidney cancer	1.23e-06	1.39e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.31e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.29e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—kidney cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.83e-07	1.11e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.59e-07	8.54e-06	CbGpPWpGaD
